Optimizing outcome of recurrent hepatitis C virus genotype 4 after living donor liver transplantation: moving forward by looking back
Dabbous, H M; Mahmoud El-Meteini; Sakr, M A; Montasser, I.F.; Bahaa, M.; Abdelaal, A; Fathy, M; Refaie, R; Seyam, M; Abdelmonem, A; Mukhtar, A; Hegazy, N; Almoneiri, M;
Abstract
Recurrence of HCV after LDLT is almost universal. Different factors affect response to treatment. Few data are available regarding outcome of recurrent HCV genotype 4. The purpose of this study is to improve outcome of recurrent HCV genotype 4 after LDLT.
Other data
| Title | Optimizing outcome of recurrent hepatitis C virus genotype 4 after living donor liver transplantation: moving forward by looking back | Authors | Dabbous, H M; Mahmoud El-Meteini ; Sakr, M A; Montasser, I.F. ; Bahaa, M. ; Abdelaal, A; Fathy, M; Refaie, R; Seyam, M; Abdelmonem, A; Mukhtar, A; Hegazy, N; Almoneiri, M | Keywords | INTERFERON-ALPHA-2B PLUS RIBAVIRIN;SUSTAINED VIROLOGICAL RESPONSE;PEGYLATED-INTERFERON;ANTIVIRAL THERAPY;PEGINTERFERON ALPHA-2B;INFECTED PATIENTS;FIBROSIS PROGRESSION;INITIAL TREATMENT;HCV REINFECTION;PEG-INTERFERON | Issue Date | Apr-2014 | Publisher | ELSEVIER SCIENCE INC | Journal | Transplantation proceedings | Volume | 46 | Issue | 3 | Start page | 822 | End page | 827 | ISSN | 0041-1345 | DOI | 10.1016/j.transproceed.2013.11.152 | PubMed ID | 24767357 | Scopus ID | 2-s2.0-84899501351 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.